HRMY Harmony Biosciences Holdings

$34.31

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.

Website: https://www.harmonybiosciences.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1802665
Address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, US
Valuation
Market Cap
$1.63B
P/E Ratio
11.34
PEG Ratio
nan
Price to Book
2.48
Performance
EPS
$2.51
Dividend Yield
—
Profit Margin
20.40%
ROE
25.80%
Technicals
50D MA
$33.47
200D MA
$34.76
52W High
$41.61
52W Low
$26.47
Fundamentals
Shares Outstanding
57M
Target Price
$51.89
Beta
0.80

HRMY EPS Estimates vs Actual

● Estimated
● Actual

HRMY News & Sentiment

Nov 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Harmony Biosciences Holdings, Inc. ( HRMY ) Q3 Earnings Miss Estimates
Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -5.43% and +4.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 29, 2025 • Zacks Commentary NEUTRAL
Earnings Preview: Jazz Pharmaceuticals ( JAZZ ) Q3 Earnings Expected to Decline
Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 28, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Harmony Biosciences Holdings, Inc. ( HRMY ) Earnings Expected to Grow: Should You Buy?
Harmony Biosciences (HRMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 24, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Harmony Biosciences ( HRMY ) Moves 12.7% Higher: Will This Strength Last?
Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Oct 09, 2025 • Zacks Commentary NEUTRAL
Nurix Therapeutics, Inc. ( NRIX ) Reports Q3 Loss, Misses Revenue Estimates
Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -22.62% and -57.71%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 06, 2025 • Benzinga NEUTRAL
Top 3 Health Care Stocks That Are Preparing To Pump In Q4 - Harmony Biosciences Hldgs ( NASDAQ:HRMY ) , CorVel ( NASDAQ:CRVL )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Sentiment Snapshot

Average Sentiment Score:

0.280
50 articles with scored sentiment

Overall Sentiment:

Bullish

HRMY Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
0.2 Surprise
  • Reported EPS: $0.92
  • Estimate: $0.72
  • Whisper: —
  • Surprise %: 27.8%
May 06, 2025
Mar 31, 2025 (Pre market)
-0.14 Surprise
  • Reported EPS: $0.78
  • Estimate: $0.91
  • Whisper: —
  • Surprise %: -14.8%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.26 Surprise
  • Reported EPS: $1.08
  • Estimate: $0.82
  • Whisper: —
  • Surprise %: 32.2%
Oct 29, 2024
Sep 30, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $0.79
  • Estimate: $0.67
  • Whisper: —
  • Surprise %: 17.9%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.26 Surprise
  • Reported EPS: $0.20
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: 433.3%
Apr 30, 2024
Mar 31, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $0.67
  • Estimate: $0.60
  • Whisper: —
  • Surprise %: 11.7%
Feb 22, 2024
Dec 31, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.45
  • Estimate: $0.48
  • Whisper: —
  • Surprise %: -6.2%
Oct 31, 2023
Sep 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $0.75
  • Estimate: $0.65
  • Whisper: —
  • Surprise %: 15.4%
Aug 01, 2023
Jun 30, 2023 (Pre market)
-0.07 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.63
  • Whisper: —
  • Surprise %: -11.1%

Financials